U.S., Feb. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07433400) titled 'Long-term Progression of Patients Treated and Monitored for Relapsed or Refractory Ph+ ALL' on Jan. 20.
Brief Summary: The objective of this retrospective study is to examine the outcome of patients who relapse with Ph+ ALL and to potentially identify response profiles in order toadvance the treatment regimens that can be offered.
Study Start Date: Aug. 29, 2025
Study Type: OBSERVATIONAL
Condition:
Ph Positive ALL
Recruitment Status: RECRUITING
Sponsor: Group for Research in Adult Acute Lymphoblastic Leukemia
Disclaimer: Curated by HT Syndication....